
A PRIVATE INVESTMENT FIRM FOCUSED ON POWER, ENERGY, MEDTECH AND INDUSTRIAL BIOTECH

A PRIVATE INVESTMENT FIRM FOCUSED ON POWER, ENERGY AND INDUSTRIAL BIOTECH INVESTMENTS.

A PRIVATE INVESTMENT FIRM FOCUSED ON POWER, ENERGY AND INDUSTRIAL BIOTECH INVESTMENTS.

A PRIVATE INVESTMENT FIRM FOCUSED ON POWER, ENERGY AND INDUSTRIAL BIOTECH INVESTMENTS.
About
A PRIVATE INVESTMENT FIRM FOCUSED ON POWER, ENERGY, MEDTECH AND INDUSTRIAL BIOTECH
Valquest is an independent private investor and investment manager focusing on high quality, long-life assets
We source, shape and scale-up venture capital and private equity investments mostly in the Energy, Power, MedTech and Industrial Biotech sectors
Our portfolio is composed of investments primarily located in Europe with some in the GCC
Principals
Fadi Noureddine
Valquest Partners founder and managing partner since 2013
Morgan Stanley
Lehman Brothers
Citi Samba
M&A, ECM advisor with Petrochemicals, Energy and Power expertise, PE & VC principal across Europe, the Gulf and MENA since 1998
Walid Sfeir
Valquest Partners founder and managing partner since 2013
McKinsey & Company
Valeo
KFF Holding
Procter & Gamble
Strategy, Operations and Industrial C-level with FMCG, Automotive and Energy expertise, PE & VC principal across Europe, South America and MENA since 1996
Founders are supported by a team of analysts, industrial and scientific advisors across several industries to accompany every investment
Selected Portfolio
Contact
info@val-quest.com
Lebanon
2 Tarazi bldg. Uruguay street
1144 Marfaa’ Beirut, Lebanon
Luxembourg
127, rue de Mühlenbach
L-2168 Luxembourg
Cyprus
17 GR Xenoupoulou street
3106 Limassol, Cyprus
Valquest co-invested in Tissium SA a European MedTech company that has developed an innovative polymer solution set to revolutionize the field of tissue reconstruction in multiple therapeutic areas
Valquest is leveraging its network to help Tissium expand its route to market in select MENA and Indian subcontinent markets
Valquest is at a stage to accompany the resource deployment for the launch of Tissium first therapeutical application in the US market
www.tissium.com